What's in Mostafa Hassanein, Msc's pipeline?

Mostafa Hassanein, Msc has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Mostafa Hassanein, Msc's portfolio?

Top competitors by shared drug class: Hospital for Special Surgery, New York, University Hospitals Cleveland Medical Center.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/mostafa-hassanein-msc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Mostafa Hassanein, Msc — Portfolio Competitive Intelligence Brief

Mostafa Hassanein, Msc pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Autologous platelets rich plasma	Autologous platelets rich plasma	marketed	Autologous cell therapy / Regenerative medicine product		Orthopedics, Regenerative Medicine, Wound Healing

Therapeutic area mix

Orthopedics, Regenerative Medicine, Wound Healing · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Hospital for Special Surgery, New York · 1 shared drug class
University Hospitals Cleveland Medical Center · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Mostafa Hassanein, Msc:

Cite this brief

Drug Landscape (2026). Mostafa Hassanein, Msc — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/mostafa-hassanein-msc. Accessed 2026-05-16.